U.S. Physical Therapy, Inc.

U.S. Physical Therapy, Inc. operates a network of physical and occupational therapy clinics, as well as providing contract therapy services. The company generates revenue primarily through fees for therapeutic services, often reimbursed by insurance providers, establishing itself as a significant player within the fragmented rehabilitation services market. Its competitive advantage stems from its extensive geographic footprint and clinic ownership model.

Looking at multi-year financials, revenue has shown consistent growth, climbing from 495.0M in 2021 to a projected 781.0M in 2025. Net income has fluctuated, peaking at 40.8M in 2021 before a projected 39.6M in 2025, with a dip to 28.2M in 2023. Operating cash flow has generally been robust, ranging from 58.5M in 2022 to 82.0M in 2023, and cash on hand has varied significantly, from 28.6M in 2021 to 152.8M in 2023, before settling at a projected 35.6M in 2025.

A key strength lies in its predictable revenue streams from an aging population demanding rehabilitation services, coupled with a resilient operating cash flow generation. However, significant risks include potential changes in healthcare reimbursement policies and the ongoing challenge of managing labor costs for qualified therapists. Investors should monitor trends in patient volumes and the company's ability to integrate acquired clinics efficiently to sustain profitability.